Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now follows an extensive grant approval process to ensure your dollars make the biggest impact to homerun cancer research. Take comfort in knowing that The Cure Starts Now only funds: research that follows our mission, research that is non-duplicative, and research that is financially sound.
The Cure Starts Now has funded $25,466,182 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 170 grants at over 100 hospitals in 29 countries.

Children's Cancer Institute (AU) - $185,706
$185,706.00
October 2017
Developing novel combination therapeutic approaches for DIPG targeting Polo-like Kinase 1

Children's National Medical Center - $200,000
$200,000.00
October 2017
Validation of TAK228 as an effective drug for treating children with DIPG

Ann & Robert H. Lurie Children's Hospital - $100,000
$100,000.00
October 2017
Determine the efficacy of BMP and MEK inhibitors with RT to treat ACVR1 mutant DIPG

Anschutz Medical Campus - $50,000
$50,000.00
September 2017
Toward a Multimodality Cure for DIPG: Investigation of Intratumoral Drug Penetration and Craniospinal Irradiation.

Massachusetts General Hospital - $50,000
$50,000.00
September 2017
Repurposing Mefloquine for Diffuse Intrinsic Pontine Glioma Therapy

CONNECT Consortium - $893,678.37
$893,678.00
September 2017
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

University of Massachusetts Medical School - $50,000
$50,000.00
May 2017
Advanced RNAi therapeutics for DIPG

Lucile Packard Children's Hospital Stanford - $50,000
$50,000.00
May 2017
Cellular Cybercriminals: DIPG Hacks into the Neural Communication Infrastructure

Hospital for Sick Children - $50,000
$50,000.00
September 2016
MRI Guided Focused Ultrasound: Targeted Drug Delivery in Diffuse Intrinsic Pontine Glioma

Gustave Roussy Cancer Center - $93,071
$93,071.00
September 2016
Ultrasound-induced delivery of Panobinostat in preclinical models

The Hospital for Sick Children - $194,260
$194,260.00
September 2016
Exploring the interactome of H3K27M to find therapeutic targets for DIPG

Cold Spring Harbor Laboratory - $100,000
$100,000.00
September 2016
Allele-specific antisense therapy for DIPG

Children's Cancer Institute - $143,884
$143,884.00
September 2016
Radiosensitisation of Diffuse Intrinsic Pontine Gliomas by modulating the glucose metabolism

Dana-Farber Cancer Institute - $100,000
$100,000.00
December 2015
Characterizing resistance mechanisms to radiation therapy and adjuvant chemotherapy in Diffuse Intrinsic Pontine Glioma

Cincinnati Children's Hospital Medical Center - $100,000
$100,000.00
December 2015
An early Phase 2 Study of LEE011, a CDK4/6 Inhibitor, following radiation therapy in Children with Newly Diagnosed non-biopsied Diffuse Pontine Gliomas (DIPG) and Rb+ biopsied DIPG and High Grade Gliomas (HGG)